Global Migraine Therapy Device Market Growth (Status and Outlook) 2025-2031
Description
The global Migraine Therapy Device market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
A migraine therapy device refers to a device or apparatus designed to help alleviate or manage the symptoms of migraines. Migraine is a neurological condition characterized by severe recurring headaches, often accompanied by other symptoms such as nausea, sensitivity to light and sound, and visual disturbances.
United States market for Migraine Therapy Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Migraine Therapy Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Migraine Therapy Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Migraine Therapy Device players cover Cefaly, Theranica Bio-Electronics Ltd., ShiraTronics, Neurolief Inc., electroCore, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Migraine Therapy Device Industry Forecast” looks at past sales and reviews total world Migraine Therapy Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Migraine Therapy Device sales for 2025 through 2031. With Migraine Therapy Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Migraine Therapy Device industry.
This Insight Report provides a comprehensive analysis of the global Migraine Therapy Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Migraine Therapy Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Migraine Therapy Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Migraine Therapy Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Migraine Therapy Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Migraine Therapy Device market by product type, application, key players and key regions and countries.
Segmentation by Type:
Non-invasive Treatment
Implant Treatment
Segmentation by Application:
Hospital
Clinic
Residential
Nursing Home
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cefaly
Theranica Bio-Electronics Ltd.
ShiraTronics
Neurolief Inc.
electroCore, Inc.
Salvia BioElectronics
eNeura Inc.
Softeq Development
Please note: The report will take approximately 2 business days to prepare and deliver.
A migraine therapy device refers to a device or apparatus designed to help alleviate or manage the symptoms of migraines. Migraine is a neurological condition characterized by severe recurring headaches, often accompanied by other symptoms such as nausea, sensitivity to light and sound, and visual disturbances.
United States market for Migraine Therapy Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Migraine Therapy Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Migraine Therapy Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Migraine Therapy Device players cover Cefaly, Theranica Bio-Electronics Ltd., ShiraTronics, Neurolief Inc., electroCore, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Migraine Therapy Device Industry Forecast” looks at past sales and reviews total world Migraine Therapy Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Migraine Therapy Device sales for 2025 through 2031. With Migraine Therapy Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Migraine Therapy Device industry.
This Insight Report provides a comprehensive analysis of the global Migraine Therapy Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Migraine Therapy Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Migraine Therapy Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Migraine Therapy Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Migraine Therapy Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Migraine Therapy Device market by product type, application, key players and key regions and countries.
Segmentation by Type:
Non-invasive Treatment
Implant Treatment
Segmentation by Application:
Hospital
Clinic
Residential
Nursing Home
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cefaly
Theranica Bio-Electronics Ltd.
ShiraTronics
Neurolief Inc.
electroCore, Inc.
Salvia BioElectronics
eNeura Inc.
Softeq Development
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
88 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Migraine Therapy Device Market Size by Player
- 4 Migraine Therapy Device by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Migraine Therapy Device Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
